Trials / Completed
CompletedNCT04819581
Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects
An Open-label, Randomized, Four-treatment, Four-sequence, Four-period, Crossover, Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Scilex Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the systemic exposure and pharmacokinetic parameters of SP-103 topical system following one, two, or three topical system applications and compare to the pharmacokinetics of ZTlido.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SP-103 | lidocaine topical system 5.4% |
| DRUG | ZTlido | lidocaine topical system 1.8% |
Timeline
- Start date
- 2019-08-03
- Primary completion
- 2019-08-27
- Completion
- 2019-08-27
- First posted
- 2021-03-29
- Last updated
- 2021-03-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04819581. Inclusion in this directory is not an endorsement.